No. | Age | Sex | Smoking | VC (l) | FEV1 (l) | %TLC (%) | %Tlco (%) | Cst (l/cmH2O) | NO (ppb) | Medication |
---|---|---|---|---|---|---|---|---|---|---|
NO=nitric oxide; iNOS=inducible NO synthase; NT=nitrotyrosine; Ex=ex-smoker; ND=not done; T=theophylline; AC=anticholinergic agents; B=β adrenoceptor agonists; VC=vital capacity; FEV1=forced expiratory volume in 1 second; TLC=total lung capacity; Tlco=carbon monoxide transfer factor; Cst=static compliance; NO=nitric oxide. | ||||||||||
Steroid treatment group | ||||||||||
1 | 49 | M | Ex | 3.97 | 1.43 | 131 | 36.5 | 0.47 | 16 | T, AC |
2 | 70 | M | Ex | 1.53 | 0.68 | 143 | 35.0 | 0.33 | 10 | T, AC, B |
3 | 72 | M | Ex | 1.66 | 0.79 | 123 | 26.2 | 0.36 | 13 | T, AC |
4 | 53 | M | Ex | 3.85 | 1.46 | 120 | 45.2 | 0.50 | 10 | T |
5 | 71 | M | Ex | 2.88 | 0.85 | 124 | 36.9 | 0.34 | 15 | T, AC, B |
6 | 75 | M | Ex | 2.79 | 0.69 | 112 | 45.5 | 0.32 | 14 | T |
7 | 71 | M | Ex | 2.99 | 1.05 | 107 | 52.4 | 0.46 | 18 | T, AC, B |
8 | 69 | M | Ex | 3.17 | 1.02 | 149 | 39.2 | 0.49 | 8 | T, B |
9 | 69 | M | Ex | 2.33 | 1.22 | 120 | 51.7 | 0.31 | 9 | T |
10 | 64 | M | Ex | 3.25 | 1.33 | N.D. | N.D. | 0.35 | 7 | T, AC |
11 | 67 | F | Ex | 2.50 | 1.45 | 109 | 53.0 | N.D. | 30 | T |
12 | 69 | M | Ex | 3.23 | 1.07 | 123 | 60.3 | N.D. | 14 | T, AC |
Mean | 66.6 | 2.85 | 1.09 | 125 | 41.0 | 0.39 | 13.7 | |||
SE | 2.4 | 0.23 | 0.09 | 4.2 | 3.2 | 0.03 | 1.9 | |||
Placebo treatment group | ||||||||||
13 | 65 | M | Ex | 2.49 | 0.66 | 146 | 45.2 | 0.45 | 26 | T, AC, B |
14 | 65 | M | Ex | 4.24 | 1.97 | 122 | 40.4 | 0.32 | 5 | T, AC, B |
15 | 76 | M | Ex | 2.54 | 1.75 | 124 | 46.5 | 0.33 | 11 | T, AC |
16 | 65 | F | Ex | 2.96 | 1.70 | 104 | 52.9 | 0.29 | 17 | T, B |
17 | 69 | M | Ex | 3.35 | 1.09 | 131 | 38.4 | 0.42 | 11 | T, AC, B |
18 | 65 | M | Ex | 2.99 | 1.35 | 130 | 28.9 | 0.46 | 5 | T, AC, B |
Mean | 67.5 | 3.10 | 1.42 | 126 | 42.1 | 0.38 | 12.5 | |||
SE | 2.0 | 0.29 | 0.22 | 6.1 | 3.7 | 0.03 | 3.6 |